IRIS Accounts Production v18.3.1.65 07185420 director 1.4.17 31.3.18 31.3.18 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure071854202017-03-31071854202018-03-31071854202017-04-012018-03-31071854202016-03-31071854202016-04-012017-03-31071854202017-03-3107185420ns15:EnglandWales2017-04-012018-03-3107185420ns14:PoundSterling2017-04-012018-03-3107185420ns10:Director12017-04-012018-03-3107185420ns10:PrivateLimitedCompanyLtd2017-04-012018-03-3107185420ns10:SmallEntities2017-04-012018-03-3107185420ns10:AuditExemptWithAccountantsReport2017-04-012018-03-3107185420ns10:SmallCompaniesRegimeForDirectorsReport2017-04-012018-03-3107185420ns10:SmallCompaniesRegimeForAccounts2017-04-012018-03-3107185420ns10:FullAccounts2017-04-012018-03-3107185420ns10:CompanySecretary12017-04-012018-03-3107185420ns10:RegisteredOffice2017-04-012018-03-3107185420ns5:CurrentFinancialInstruments2018-03-3107185420ns5:CurrentFinancialInstruments2017-03-3107185420ns5:ShareCapital2018-03-3107185420ns5:ShareCapital2017-03-3107185420ns5:RetainedEarningsAccumulatedLosses2018-03-3107185420ns5:RetainedEarningsAccumulatedLosses2017-03-3107185420ns5:LeaseholdImprovements2017-04-012018-03-3107185420ns5:FurnitureFittings2017-04-012018-03-3107185420ns5:ComputerEquipment2017-04-012018-03-3107185420ns5:LeaseholdImprovements2017-03-3107185420ns5:FurnitureFittings2017-03-3107185420ns5:ComputerEquipment2017-03-3107185420ns5:LeaseholdImprovements2018-03-3107185420ns5:FurnitureFittings2018-03-3107185420ns5:ComputerEquipment2018-03-3107185420ns5:LeaseholdImprovements2017-03-3107185420ns5:FurnitureFittings2017-03-3107185420ns5:ComputerEquipment2017-03-3107185420ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-3107185420ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-03-31


REGISTERED NUMBER: 07185420 (England and Wales)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2018

FOR

ACTIVE PHARMA SUPPORT LIMITED

ACTIVE PHARMA SUPPORT LIMITED (REGISTERED NUMBER: 07185420)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Report of the Accountants 5

ACTIVE PHARMA SUPPORT LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2018







DIRECTOR: Mrs L Whitlock





SECRETARY:





REGISTERED OFFICE: Georgia
165 Dover Road
Sandwich
Kent
CT13 0DD





REGISTERED NUMBER: 07185420 (England and Wales)





ACCOUNTANTS: Higson APS Limited
45 Queen Street
Deal
Kent
CT14 6EY

ACTIVE PHARMA SUPPORT LIMITED (REGISTERED NUMBER: 07185420)

BALANCE SHEET
31 MARCH 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 11,904 12,917
Investment property 5 12,197 -
24,101 12,917

CURRENT ASSETS
Debtors 6 262 4,083
Cash at bank 27,359 29,465
27,621 33,548
CREDITORS
Amounts falling due within one year 7 35,906 30,609
NET CURRENT (LIABILITIES)/ASSETS (8,285 ) 2,939
TOTAL ASSETS LESS CURRENT
LIABILITIES

15,816

15,856

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 15,716 15,756
SHAREHOLDERS' FUNDS 15,816 15,856

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 21 December 2018 and were signed by:





Mrs L Whitlock - Director


ACTIVE PHARMA SUPPORT LIMITED (REGISTERED NUMBER: 07185420)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018

1. STATUTORY INFORMATION

Active Pharma Support Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - Straight line over 20 years
Fixtures and fittings - 15% on reducing balance
Computer equipment - 33% on cost

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in
fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2017 - 1 ) .

ACTIVE PHARMA SUPPORT LIMITED (REGISTERED NUMBER: 07185420)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2018

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 1 April 2017
and 31 March 2018 11,833 4,227 2,201 18,261
DEPRECIATION
At 1 April 2017 1,726 1,417 2,201 5,344
Charge for year 592 421 - 1,013
At 31 March 2018 2,318 1,838 2,201 6,357
NET BOOK VALUE
At 31 March 2018 9,515 2,389 - 11,904
At 31 March 2017 10,107 2,810 - 12,917

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
Additions 12,197
At 31 March 2018 12,197
NET BOOK VALUE
At 31 March 2018 12,197

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Tax - 3,960
VAT 262 123
262 4,083

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Tax 30 -
Directors' current accounts 35,246 30,038
Accrued expenses 630 571
35,906 30,609

ACTIVE PHARMA SUPPORT LIMITED

REPORT OF THE ACCOUNTANTS TO THE DIRECTOR OF
ACTIVE PHARMA SUPPORT LIMITED

The following reproduces the text of the report prepared for the director and members in respect of the
company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is
only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other
primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 March 2018 set out on pages to and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Higson APS Limited
45 Queen Street
Deal
Kent
CT14 6EY


21 December 2018